US Broker Ratings

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Navigating a Promising 28.52% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a key player in the biotechnology sector, has drawn significant attention from investors, particularly due to its promising pipeline in treating metabolic dysfunction-associated steatohepatitis (MASH)...

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 25.96% Potential Upside Amid Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, offers a compelling investment opportunity with a potential upside..

BrightSpring Health Services (BTSG) Stock Analysis: A Healthcare Powerhouse with Robust Revenue Growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has emerged as a formidable player in the healthcare sector, particularly within the health information services industry. Headquartered in Louisville, Kentucky, this company has..

Corcept Therapeutics (CORT) Stock Analysis: Riding High with Strong Analyst Support and Market Cap

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector with its innovative approach to developing medications for serious medical conditions. As of today, the company boasts a..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring an 83% Upside Potential in the RNA Therapeutics Market

For investors seeking opportunities in the burgeoning field of RNA therapeutics, Atrium Therapeutics, Inc. (NASDAQ: RNA) presents a compelling case. With a market capitalization of $233.49 million, this San Diego-based..

Axsome Therapeutics (AXSM) Stock Analysis: Unveiling a 13% Potential Upside Amid Robust Revenue Growth

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands out in the biotech sector with its impressive market capitalization of $12.57 billion. Focused on developing innovative treatments for central nervous system (CNS) disorders,..

RadNet, Inc. (RDNT) Investor Outlook: Strong Buy Ratings and 30% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, is catching the eye of savvy investors with its compelling growth prospects and robust..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating the 13.91% Potential Upside

Thermo Fisher Scientific Inc (TMO), a behemoth in the healthcare sector with a market capitalization of $194.52 billion, stands as a pivotal player in the diagnostics and research industry. Headquartered..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Strategic Play with 20.83% Potential Upside

Investors eyeing the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) to be a compelling prospect. With a market capitalization of $29.82 billion, GE HealthCare Technologies, a key..

Option Care Health, Inc. (OPCH) Stock Analysis: A 30.52% Potential Upside Ignites Investor Interest

Option Care Health, Inc. (NASDAQ: OPCH), a significant player in the healthcare sector with a focus on medical care facilities, offers a compelling opportunity for investors seeking exposure to the..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Examining the Biotech Firm’s Growth Potential and Market Position

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, stands at the forefront of developing transformative therapies for rare diseases. With a market capitalization of $2.04 billion, this..

Insulet Corporation (PODD) Investor Outlook: Analyzing a 46% Potential Upside

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with an enticing potential upside of 46.07%. With a..

Encompass Health Corporation (EHC) Stock Analysis: A 31.97% Upside Potential Amid Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC), a leading provider in the healthcare sector, particularly in the field of medical care facilities, offers a promising investment opportunity with a substantial potential upside..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling 70% Growth Potential with Innovative Organ Care Systems

TransMedics Group, Inc. (NASDAQ: TMDX) is making significant strides in the healthcare sector, specifically in the medical devices industry. With its pioneering Organ Care System (OCS), TransMedics is transforming organ..

The Ensign Group, Inc. (ENSG) Investor Outlook: Capturing a 31% Potential Upside in Healthcare

The Ensign Group, Inc. (NASDAQ: ENSG) is garnering significant attention from investors, and rightfully so. As a stalwart in the healthcare sector, Ensign operates extensively across the United States, providing..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Solid Healthcare Play with a 0.85% Upside Potential

Investors looking for a robust player in the healthcare sector should consider Elevance Health, Inc. (NYSE: ELV), a prominent name in the healthcare plans industry. With a formidable market cap..

BioNTech SE (BNTX) Stock Analysis: Exploring a 24.93% Upside Potential Amidst Diverse Clinical Trials

BioNTech SE (NASDAQ: BNTX), a pioneering biotechnology company headquartered in Mainz, Germany, is renowned for its development and commercialization of immunotherapies. With a market cap of $24.67 billion, BioNTech is..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook Reveals 48.92% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands out as a formidable player in the biotechnology sector, focusing on developing therapies for rare diseases. With a market cap of $11.4 billion, this..

United Therapeutics Corporation (UTHR) Stock Analysis: A Closer Look at Its 19.67% Potential Upside

For investors eyeing the healthcare sector, United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity. With a market capitalization of $23.6 billion, this specialty drug manufacturer is not only making..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Look at Growth Potential and Analyst Consensus

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, is making significant strides in the drug manufacturing industry, particularly in the specialty and generic markets. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds